BioTime announces 21 new stem cell products on the market BioTime, Inc sulbutiamine depression . announced today that on August 1, 2010 the ongoing organization will be offering on the market 21 new stem cell products for research only use. These products includes the novel stem cell lines: E120 expressing the gene LGR5 useful in cancer of the colon drug discovery, EN16, T43, RAD20.5, RA-SKEL8, SM22, and Z1, full properties that will be disclosed on item launch, along with differentiation packages and media for the culture of every relative line.

Other entries from category "prevention":

Random entries